While the frequency of alterations in cGAS and STING in tumours other than colorectal and melanoma remains to be ascertained, transcriptional repression by promoter hypermethylation is usually observed34, 36, suggesting the therapeutic potential for demethylating agents to rescue responsiveness to radiation and immune checkpoint inhibitors. This evidence concerns the gene CGAS and melanoma.